Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pneumocystosis.

E M Bernard1, K A Sepkowitz, E E Telzak

  • 1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York.

The Medical Clinics of North America
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mycobacterium haemophilum infections in bone marrow transplant recipients.

Transplantation·1995
Same author

Patients' views of priority setting in health care: an interview survey in one practice.

BMJ (Clinical research ed.)·1995
Same author

Direct observations of surgical wound infections at a comprehensive cancer center.

Archives of surgery (Chicago, Ill. : 1960)·1995
Same author

Treatment of opportunistic infections in AIDS.

Lancet (London, England)·1995
Same author

A corporate needs assessment for the purchase of district nursing: a qualitative approach.

Public health·1995
Same author

Crouzon and Apert syndromes: intracranial volume measurements before and after cranio-orbital reshaping in childhood.

Plastic and reconstructive surgery·1995
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Pneumocystosis is a preventable and treatable infection in HIV patients. Advances in diagnosis and treatment, including prophylaxis, have improved outcomes, though further research is needed.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Public Health

Background:

  • Pneumocystosis is a major opportunistic infection in HIV/AIDS patients.
  • Antiretroviral therapy alone does not prevent pneumocystosis.
  • Diagnosis and treatment have improved, but challenges remain.

Purpose of the Study:

  • To review the current understanding and management of pneumocystosis in HIV disease.
  • To highlight progress made in prophylaxis and treatment over the past decade.
  • To identify areas for future research and development.

Main Methods:

  • Review of existing literature on pneumocystosis in HIV.
  • Analysis of diagnostic advancements, including sputum induction and monoclonal antibodies.
  • Evaluation of current treatment and prophylaxis strategies, including medications and adjunctive therapies.

Related Experiment Videos

Main Results:

  • Pneumocystosis is preventable and treatable, with improved understanding of prophylaxis initiation.
  • Invasive procedures are often still required for diagnosis, despite modest improvements.
  • Trimethoprim-sulfamethoxazole and pentamidine are mainstays for treatment; steroids are useful adjuncts.
  • Trimethoprim-sulfamethoxazole is effective and cost-efficient for prophylaxis, but comparative data are pending.

Conclusions:

  • Significant progress has been made in combating pneumocystosis in HIV patients.
  • New diagnostic technologies and therapeutic agents are anticipated to further improve control.
  • Continued research is essential for optimizing prophylaxis and treatment strategies.